RT Journal Article
SR Electronic
T1 High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008325
DO 10.1136/jitc-2023-008325
VO 12
IS 3
A1 Rischin, Danny
A1 Hughes, Brett G M
A1 Basset-Séguin, Nicole
A1 Schadendorf, Dirk
A1 Bowyer, Samantha
A1 Trabelsi Messai, Sabiha
A1 Meier, Friedegund
A1 Eigentler, Thomas K
A1 Casado Echarren, Victoria
A1 Stein, Brian
A1 Beylot-Barry, Marie
A1 Dalac, Sophie
A1 Dréno, Brigitte
A1 Migden, Michael R
A1 Hauschild, Axel
A1 Schmults, Chrysalyne D
A1 Lim, Annette M
A1 Yoo, Suk-Young
A1 Paccaly, Anne J
A1 Papachristos, Apostolos
A1 Nguyen, Jenny-Hoa
A1 Okoye, Emmanuel
A1 Seebach, Frank
A1 Booth, Jocelyn
A1 Lowy, Israel
A1 Fury, Matthew G
A1 Guminski, Alexander
YR 2024
UL http://jitc.bmj.com/content/12/3/e008325.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.